Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. OWC Pharmaceutical Research Corp. (OWCP) Message Board

Details are below on the whereabouts of these pate

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 15624
(Total Views: 706)
Posted On: 04/27/2019 2:34:50 PM
Posted By: Joe Money
Re: Hitbodedut10 #15028
Details are below on the whereabouts of these patents nearing grant.

USPTO patents are nearing patent grant! Patents 15629230, 15573687, and 15580718 received a NON-FINAL rejection letters and have been responded to by OWC. The rejection is to the point where it only contained minor updates to be made in order to obtain patent grants. This is absolutely true despite some trying to hide the fact that grants are on the way!!

United States Patent and Trademark Office (USPTO)

https://www.uspto.gov/patents-application-pro...ch-patents

For USPTO patents, use the link then click on “Visit Pair” under Patent Application Information Retrieval (PAIR) and then click on “Check the status of a published application” and search by the Application Number (patent application # 15629230, 15573687, 15580718, 15536738, 15708187, 15533684, and 15531047). Once you’re into an application, click on the Image File Wrapper tab to open documents.

Multiple Myeloma

For Multiple Myeloma patent 15580718, the examiner claims the patent infringes on Perez Simon’s patent. This is the last milestone to overcome. OWC argues that Simon’s MM treatment is solely a CBD agent, whereas OWC’s treatment is a combination of CBD+THC+CFZ.

Conclusion statement from OWC:

“Applicant believes the claims are in allowable condition. A notice of allowance for this application is solicited earnestly. If the Examiner is of the opinion that all claims currently pending or not allowable, Applicant’s counsel respectfully requests a telephone interview to resolve any outstanding issues and the Examiner is invited to call Applicant’s agent.”

Fibromyalgia

For the Fibromyalgia patent 15573687, the only patent claims that are pending are 88-108. And the only examiner remark is that the patent needs to form a single general inventive concept (one invention only). OWC has a group of inventions in this patent so there needs to be a technical relationship among these inventions for it to be acceptable. In other words, OWC is trying to keep their patent broad, but need to narrow it down to be accepted.

Skin Disorders

For the Skin Disorders patent 15629230, the only patent claims that are pending are 1-23. And the only examiner remark is that the inventions within the patent are independent or distinct for one another, similar to the fibromyalgia patent.


(2)
(0)




OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us